Reactivations after 5-methoxy-N,N-dimethyltryptamine use in naturalistic settings
An initial exploratory analysis of the phenomenon’s predictors and its emotional valence
Dados Bibliográficos
| ID | 15518878 |
|---|---|
| Autores | Ana María Ortiz Bernal (0000-0003-3304-6497, University of Wisconsin–Madison, autor correspondente), Charles L Raison (0000-0001-6687-0066, University of Wisconsin–Madison), Rafaelle L Lancelotta (0000-0002-7789-3463, The Ohio State University), Rafael L Lancelotta, A K Davis (0000-0003-4770-8893, The Ohio State University) |
| Ano | 2022 |
| Volume | 13 |
| Páginas | 1049643-1049643 |
| Data de publicação | 2022-11-29 |
| Peer Reviewed | Sim |
| Open Access | Sim |
| Tipo | ARTICLE |
| Periódico | Frontiers in Psychiatry (JOURNAL) |
| Identificadores do periódico | ISSN: 1664-0640 • E-ISSN: 1664-0640 |
| Editora | Frontiers Media (PUBLISHER • CH) |
| DOI | 10.3389/fpsyt.2022.1049643 |
| PMID | 36523876 |
| OpenAlex | W4310207667 |
| Idioma | EN |
| Citações recebidas | 5 |
| Referências citadas | 64 |
These findings suggest that reactivation phenomena, in this particular sample may most often represent a neutral or positive byproduct of the acute 5-MeO-DMT experience. More information is needed to best identify individuals most likely to experience a reactivation as a negative event to prevent such potential challenging outcomes
Descriptive statistics · Developmental psychology · Logistic regression · Phenomenon · Valence (chemistry · Clinical Psychology · Forensic Toxicology and Drug Analysis · Medicine · Neurotransmitter Receptor Influence on Behavior · Psychedelics and Drug Studies · Psychology · Internal Medicine
MeO-DMT for post-traumatic stress disorder
Reactivations Associated with the Use of 5-MeO-DMT Among Spanish-Speaking Individuals
The Epidemiology of Psychedelic Use Among United States Military Veterans
Epidemiology of classic psychedelic substances
A Scoping Review of Research in Naturalistic Studies with Psychedelics
Psilocybin produces substantial and sustained decreases in depression and anxiety in patients with life-threatening cancer
Pilot study of the 5-HT 2A R agonist psilocybin in the treatment of tobacco addiction
Percentage of Heavy Drinking Days Following Psilocybin-Assisted Psychotherapy vs Placebo in the Treatment of Adult Patients With Alcohol Use Disorder
Validation of the revised Mystical Experience Questionnaire in experimental sessions with psilocybin
Psilocybin-Occasioned Mystical Experiences in the Treatment of Tobacco Addiction
Neural correlates of the psychedelic state as determined by fMRI studies with psilocybin
Ego-Dissolution and Psychedelics
Recall bias in epidemiologic studies
Psilocybin can occasion mystical-type experiences having substantial and sustained personal meaning and spiritual significance
Pilot Study of Psilocybin Treatment for Anxiety in Patients With Advanced-Stage Cancer
Effects of Psilocybin-Assisted Therapy on Major Depressive Disorder
Rapid and sustained symptom reduction following psilocybin treatment for anxiety and depression in patients with life-threatening cancer
Mystical-type experiences occasioned by psilocybin mediate the attribution of personal meaning and spiritual significance 14 months later
The entropic brain
Long-term follow-up of psilocybin-facilitated smoking cessation
Psilocybin with psychological support for treatment-resistant depression
Psilocybin occasioned mystical-type experiences
The Satisfaction With Life Scale
Examining psychological inflexibility as a transdiagnostic process across psychological disorders
The use of the psychological flexibility model to support psychedelic assisted therapy
Psychological flexibility mediates the relations between acute psychedelic effects and subjective decreases in depression and anxiety
Bufo alvarius
Pharmepéna-Psychonautics
Use of Benefit Enhancement Strategies among 5-Methoxy-N,N-Dimethyltryptamine (5-MeO-DMT) Users
Patients’ Accounts of Increased “Connectedness” and “Acceptance” After Psilocybin for Treatment-Resistant Depression
A comparison of reactivation experiences following vaporization and intramuscular injection (IM) of synthetic 5-methoxy-N,N-dimethyltryptamine (5-MeO-DMT) in a naturalistic setting
| Obras citantes distintas | 5 |
|---|---|
| Citações por ano | 1,67 |
| Intervalo de citações | 2023 - 2025 (3) |
| Velocidade de citação | recent |
| Altamente citado | Não |
| Tipos de citação | Neutras: 5 |